1. The India Hypertension Control Initiative steered by ICMR has been important in steering the agenda-setting for hypertension screening & treatment at scale via the PHC system 2. The NHRP (StAr-NCD) asked the RQ to improve coverage, quality for HT, DM, CRD & CAD - getting to a district level model for high quality care for DM & HT 3. WHO target to achieve <140/90 control in at least 50% & 80% of DM on treatment(?) 4. Nagpur data (NHRP formative evaluation survey data) shows huge focus on screenign with little focus on follow-up and treatment; about 1/3 for DM & 1/4 for HT received drugs for a month 5. The StAr-NCD team has come up with a 6/6 model that includes 6 core strategies addressing district/state governance, dispensing of meds for 30 days, reliable lab measue, practice targeted tracking for loss to follow-up, streamline information system and reorientation of healthcare providers with 6 supplementaty strategies including patient support group, district residency program, supportive supervision, reliable data source at facility, standard protcol adherence and leverage partenrship with academia for additional workforce. The TSU is chaired by the ZP CEO with DHOs, urban health heads and other inter-sectoral/dept officers (over 20 members!) 6. One of the site' data shows 96% of "control" among people on follow-up. Possibly indicates huge overreporting of controls possibly due to the push to report better nubmers? 7. 8. Last updated: 2026-01-23 10:19